Abstract
Development of personalized medicine is a multidisciplinary undertaking and will need teamwork by many players. Pharmaceutical and biotechnology companies have taken a leading role in this venture in keeping with their future as healthcare enterprises rather than mere developers of technologies and manufacturers of medicines. The practicing physicians will play a vital role in implementing personalized medicine. Various players in the development of personalized medicine are listed in Table 151.1. The Personalized Medicine Coalition (PMC) contains many of these players.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gurwitz D, Weizman A, Rehavi M (2003) Education: teaching pharmacogenomics to prepare future physicians and researchers for personalized medicine. Trends Pharmacol Sci 24:122–125
Jain KK (2006b) Challenges of developing personalized medicines. Curr Opin Mol Ther 8:487–492
Kohane IS, Masys DR, Altman RB (2006) The incidentalome: a threat to genomic medicine. JAMA 296:212–215
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Jain, K.K. (2009). Organization of Personalized Medicine. In: Textbook of Personalized Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0769-1_15
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0769-1_15
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0768-4
Online ISBN: 978-1-4419-0769-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)